Diagnoptics News
What's new?
Read all news items about the AGE Reader and Diagnoptics.
Review about AGE Reader in assessing CV risk and risk of diabetes
Groningen, the Netherlands – September 5, 2014.
An excellent review paper has been published in European Endocrinology this week. The authors reviewed all available clinical data on the AGE Reader and concluded that the non-invasive AGE Reader measurement shows a good predictive value (better than HbA1c) for the development of diabetic complications, microvascular and macrovascular disease, cardiovascular and overall mortality.
Besides reviewing the available clinical data the authors also give a comprehensive overview of the theoretical background on AGEs and measuring AGEs
The full-text version of this review paper can be downloaded free of charge HERE
Official reprints of this review are available free of charge at our booth on the upcoming EASD congress in Vienna (September 15-19).
Latest news items
Would you like to learn more about our products? Request any information you wish to receive here.
If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.
More information about Diagnoptics.
Information on Diagnoptics' products and Advanced Glycation Endproducts.
Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.